SEC Form 4 · accession 0001140361-18-003498
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John P Wareham
Director
Period of report
Jan 26, 2018
Accepted (ET)
Jan 29, 2018 · 12:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Jan 26, 2018 | M | 25,934 | $38.98 | A | 38,934 | D | |
| ResMed Common StockF1 | Jan 26, 2018 | S | 17,634 | $102.09 | D | 21,300 | D | |
| ResMed Common StockF2 | Jan 26, 2018 | S | 8,300 | $102.60 | D | 13,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Resmed Common Stock OptionsF3 | $38.98 | Jan 26, 2018 | M | 25,934 | D | Nov 15, 2013 | Nov 15, 2019 | ResMed Commmon Stock | 25,934 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $101.49 to $102.49. The price reported above reflects the weighted average sale price.
- F2This transaction was executed in multiple trades at prices ranging from $102.49 to $102.73. The price reported above reflects the weighted average sale price.
- F3Represents the date options became exercisable. Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholders meeting following grant date.